INFARMED Leadership Appointments: A New Era in ...

By João L. Carapinha

January 6, 2026

INFARMED Leadership Appointments: Renewed Expertise for Medicines Oversight The Portuguese Council of Ministers has issued
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control
Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidiscipl...
MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Onc...
Elderly Care Costs 2025: Rising Financial Pressures in Dutch Health Services